Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05770570 · ClinicalTrials.gov registry record · Phase 2
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
A Phase 2 study of Obesity and Overweight, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 1,785
- Enrollment target
- 1
- Study location
NCT05770570: Recruiting Phase 2 study of Obesity and Overweight, sponsored by Memorial Sloan Kettering Cancer Center.
NCT05770570 is a Phase 2 study of Obesity and Overweight that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,785 participants, above the 817-participant average among 1,053 other Obesity trials with a reported enrollment target (118% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05770570, a Phase 2 study of Obesity and Overweight, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 1,785 participants
- Enrollment target
- 1
- Study location
Study Summary
The researchers will conduct 'Taxi ROADmAP (Realizing Optimization Around Diet And Physical activity)', which also utilizes MOST, and the same 4 obesity intervention components as in SANOS, but targets the overweight/obesity crisis in another at-risk, low socioeconomic status (SES) population, taxi and for-hire vehicle (FHV) drivers (Lyft, Uber, etc.). ROADMAP also utilizes an effectiveness- implementation hybrid type 1 design. Hybrid trials, which blend effectiveness and implementation studies, can lead to more rapid translational uptake and more effective implementation. Taxi and FHV drivers are a growing, multilingual, hard-to-reach, predominantly immigrant and minority essential worker population. There are over 750,000 licensed taxi and FHV drivers in in the U.S. and over 185,000 in New York City (NYC). They have higher rates of overweight/obese range body mass index (BMI) than New Yorkers in general (77% vs 56%) and have high rates of elevated waist circumference, sedentary behavior, poor diets, and health care services underutilization. ROADmAP will test 4 evidence- and theory-based (Social Cognitive Theory \[SCT\]) behavior change intervention components. We will use MOST to identify which of the 4 components contribute most significantly and cost-effectively to weight loss among NYC drivers recruited at workplace health fairs (HFs) and virtually. Objectives are to apply MOST to design an optimized version of a scalable, lifestyle intervention for taxi/FHV drivers, and then to conduct a mixed methods multistakeholder process evaluation to facilitate widespread intervention implementation.
Primary Outcome
Efficacy of intervention is achieved when participants have weight loss with a minimum threshold of 5% of overall body weight lost Intervention components include: * Initial in-person individual diet and physical activity (PA) counseling * Thrice-weekly diet/PA text messages * Weekly telephone support * Self-monitoring tools.
Conditions Studied
Interventions
- BEHAVIORAL Counseling
- BEHAVIORAL Text Messages
- BEHAVIORAL Phone calls
- BEHAVIORAL Self-monitoring tools
Study Locations (1)
New York
- Mexican Consulate's Ventanilla de Salud (VDS) - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,785 participants |
| Start Date | 2022-12-22 |
| Est. Completion | 2027-08-11 |
| Phase | Phase 2 |
What NCT05770570 shows while recruiting
NCT05770570 is an interventional study that assigns participants to a tested intervention. Its 1,785 participants enrollment target places it among the larger protocols in the corpus, above the 817-participant average among 1,053 other Obesity trials with a reported enrollment target (118% higher).
The record links to 5 conditions, with Obesity appearing as the primary indexed condition, and to 4 interventions - of which Counseling is the first listed.
NCT05770570 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05770570 about?
NCT05770570 is a clinical study titled "Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)". The researchers will conduct 'Taxi ROADmAP (Realizing Optimization Around Diet And Physical activity)', which also utilizes MOST, and the same 4 obesity intervention components as in SANOS, but targets the overweight/obesity crisis in another at-risk, low socioeconomic status (SES) population, taxi ...
What is the current status of trial NCT05770570?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 1,785 participants. The study started on 2022-12-22. Estimated completion is 2027-08-11.
What conditions does trial NCT05770570 study?
This clinical trial studies the following conditions: Obesity, Overweight, Overweight and Obesity, Overweight or Obesity, Obese.
What interventions are being tested in trial NCT05770570?
The interventions under investigation include: Counseling (BEHAVIORAL), Text Messages (BEHAVIORAL), Phone calls (BEHAVIORAL), Self-monitoring tools (BEHAVIORAL).
Who is sponsoring clinical trial NCT05770570?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05770570 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05770570's enrollment target sits among peer trials
1,785 51st of 1053 higher than 1,003 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
RECRUITING · Phase 2
-
Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity
RECRUITING · Phase 2
-
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RECRUITING · Phase 2
-
Pharmacological and Behavioral Treatment After Bariatric Surgery
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03067181 · 1,780 participants · Phase 3
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- NCT06526650 · 1,780 participants · NA
'Ai Pono Cooking Demonstrations
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- NCT04475640 · 1,800 participants · NA
Cancer Genetic Testing in Ethnic Populations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI